InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: None

Tuesday, 11/13/2018 7:38:31 PM

Tuesday, November 13, 2018 7:38:31 PM

Post# of 425931
The theory of the lawsuit is that Amarin's management in an attempt to decieve physicians and patients utilized a substance "mineral oil" that they knew would block the actions of statins thereby raising the event risk in the placebo arm. The truth of the matter is that Amarin's management had nothing to do with the decision to use mineral oil as the placebo, a decision that was made between the trial designers and signed off on by the FDA.

I guess if you are looking for a guilty party for this decision you'd have to sue the trial designers or the FDA. Good luck.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News